Abdominal pain, a common clinical presentation, poses a significant diagnostic challenge due to its diverse etiology. A comprehensive approach to its evaluation can facilitate timely and accurate diagnosis, leading to effective patient management.
A thorough clinical history and physical examination is the cornerstone of evaluating abdominal pain. The onset, location, character, and radiation of the pain, along with associated symptoms, can provide valuable clues towards the underlying cause. Physical examination should include inspection, palpation, percussion, and auscultation, with special attention to signs of acute abdomen.
Basic laboratory tests, including complete blood count, liver function tests, renal function tests, and urinalysis, can aid in diagnosis. Imaging studies such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) can further delineate the cause of pain. Endoscopic procedures may be warranted in certain cases.
Special considerations should be given to certain populations. In women of childbearing age, gynecological causes should be considered. In elderly patients, vascular causes like mesenteric ischemia should be in the differential diagnosis. In patients with a history of surgery, postoperative complications or adhesions could be the cause.
Management should be tailored according to the underlying cause. This may range from conservative management with analgesics and dietary modifications, to surgical intervention in cases of acute abdomen. Referral to a specialist may be necessary in complex cases.
The evaluation of abdominal pain requires a systematic approach, beginning with a thorough clinical history and examination, followed by appropriate investigations. Special consideration should be given to certain populations. The management should be tailored to the underlying cause, and referral to a specialist may be necessary in complex cases. This comprehensive approach can lead to timely and accurate diagnosis, improving patient outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation